Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1986 4
1987 5
1988 5
1989 5
1990 1
1991 4
1992 5
1993 7
1994 2
1995 7
1996 6
1997 5
1998 4
1999 2
2000 6
2001 4
2002 4
2003 4
2004 4
2005 5
2006 1
2007 1
2008 1
2009 3
2010 3
2011 7
2012 6
2013 5
2014 6
2015 3
2016 3
2017 6
2018 5
2019 8
2020 4
2021 10
2022 8
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Results by year

Filters applied: . Clear all
Page 1
Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia.
Soff GA, Miao Y, Bendheim G, Batista J, Mones JV, Parameswaran R, Wilkins CR, Devlin SM, Abou-Alfa GK, Cercek A, Kemeny NE, Sarasohn DM, Mantha S. Soff GA, et al. J Clin Oncol. 2019 Nov 1;37(31):2892-2898. doi: 10.1200/JCO.18.01931. Epub 2019 Sep 23. J Clin Oncol. 2019. PMID: 31545663 Free PMC article. Clinical Trial.
A Review of Romiplostim Mechanism of Action and Clinical Applicability.
Bussel JB, Soff G, Balduzzi A, Cooper N, Lawrence T, Semple JW. Bussel JB, et al. Among authors: soff g. Drug Des Devel Ther. 2021 May 26;15:2243-2268. doi: 10.2147/DDDT.S299591. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34079225 Free PMC article. Review.
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. Farge D, et al. Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3. Lancet Oncol. 2019. PMID: 31492632
Angiostatin.
Doll JA, Soff GA. Doll JA, et al. Among authors: soff ga. Cancer Treat Res. 2005;126:175-204. doi: 10.1007/0-387-24361-5_8. Cancer Treat Res. 2005. PMID: 16209067 Review. No abstract available.
Management of Thrombocytopenia in Cancer Patients.
Mones JV, Soff G. Mones JV, et al. Among authors: soff g. Cancer Treat Res. 2019;179:139-150. doi: 10.1007/978-3-030-20315-3_9. Cancer Treat Res. 2019. PMID: 31317485 Review.
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH; CASSINI Investigators. Khorana AA, et al. Among authors: soff ga. N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630. N Engl J Med. 2019. PMID: 30786186 Clinical Trial.
172 results